Continuous blood purification treatment for endotoxin-induced acute respiratory distress syndrome

Detalhes bibliográficos
Autor(a) principal: Jiang,Y.
Data de Publicação: 2017
Outros Autores: Lin,R., Xu,Y., Zhang,S., Cui,K., Zhu,M., Li,A., Chen,C., Yang,J., Yang,W.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Medical and Biological Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000200604
Resumo: This study aimed to explore the effects of continuous blood purification (CBP) treatment in pigs affected with acute respiratory distress syndrome (ARDS). A total of 12 healthy male pigs, weighing 12±1.8 kg, were randomly and equally assigned to the control and experimental groups. The ARDS pig model was prepared by intravenous injections of endotoxin (20 µg/kg). The control group was given conventional supportive therapy, while the experimental group was given continuous veno-venous hemofiltration therapy. During the treatment process, the variations in dynamic lung compliance, oxygenation index, hemodynamics, and urine volume per hour at different times (Baseline, 0, 2, 4, and 6 h) were recorded. The levels of tumor necrosis factor (TNF-α), interleukin 6 (IL-6), and IL-10 in serum and bronchoalveolar lavage fluid (BALF) were measured using the enzyme-linked immunosorbent assay. The histomorphological changes of the lung, heart, and kidney were visualized using a light microscope. The nuclear factor κB p65 protein content of the heart, lung, and kidney tissues was also detected using western blot. The experimental group outperformed the control group in both respiratory and hemodynamic events. CBP treatment cleared TNF-α, IL-6, and IL-10 partially from serum and BALF. The pathological examination of the heart, lung, and kidney tissues revealed that the injury was less severe in the experimental group. CBP treatment can improve the organ functions of pigs affected with endotoxin-induced ARDS and protect these organs to some extent.
id ABDC-1_8f87da026267e2275a51388286a305a9
oai_identifier_str oai:scielo:S0100-879X2017000200604
network_acronym_str ABDC-1
network_name_str Brazilian Journal of Medical and Biological Research
repository_id_str
spelling Continuous blood purification treatment for endotoxin-induced acute respiratory distress syndromeAcute respiratory distress syndromeContinuous blood purification treatmentEndotoxinHemodynamicsThis study aimed to explore the effects of continuous blood purification (CBP) treatment in pigs affected with acute respiratory distress syndrome (ARDS). A total of 12 healthy male pigs, weighing 12±1.8 kg, were randomly and equally assigned to the control and experimental groups. The ARDS pig model was prepared by intravenous injections of endotoxin (20 µg/kg). The control group was given conventional supportive therapy, while the experimental group was given continuous veno-venous hemofiltration therapy. During the treatment process, the variations in dynamic lung compliance, oxygenation index, hemodynamics, and urine volume per hour at different times (Baseline, 0, 2, 4, and 6 h) were recorded. The levels of tumor necrosis factor (TNF-α), interleukin 6 (IL-6), and IL-10 in serum and bronchoalveolar lavage fluid (BALF) were measured using the enzyme-linked immunosorbent assay. The histomorphological changes of the lung, heart, and kidney were visualized using a light microscope. The nuclear factor κB p65 protein content of the heart, lung, and kidney tissues was also detected using western blot. The experimental group outperformed the control group in both respiratory and hemodynamic events. CBP treatment cleared TNF-α, IL-6, and IL-10 partially from serum and BALF. The pathological examination of the heart, lung, and kidney tissues revealed that the injury was less severe in the experimental group. CBP treatment can improve the organ functions of pigs affected with endotoxin-induced ARDS and protect these organs to some extent.Associação Brasileira de Divulgação Científica2017-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000200604Brazilian Journal of Medical and Biological Research v.50 n.2 2017reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/1414-431x20165367info:eu-repo/semantics/openAccessJiang,Y.Lin,R.Xu,Y.Zhang,S.Cui,K.Zhu,M.Li,A.Chen,C.Yang,J.Yang,W.eng2019-03-19T00:00:00Zoai:scielo:S0100-879X2017000200604Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2019-03-19T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false
dc.title.none.fl_str_mv Continuous blood purification treatment for endotoxin-induced acute respiratory distress syndrome
title Continuous blood purification treatment for endotoxin-induced acute respiratory distress syndrome
spellingShingle Continuous blood purification treatment for endotoxin-induced acute respiratory distress syndrome
Jiang,Y.
Acute respiratory distress syndrome
Continuous blood purification treatment
Endotoxin
Hemodynamics
title_short Continuous blood purification treatment for endotoxin-induced acute respiratory distress syndrome
title_full Continuous blood purification treatment for endotoxin-induced acute respiratory distress syndrome
title_fullStr Continuous blood purification treatment for endotoxin-induced acute respiratory distress syndrome
title_full_unstemmed Continuous blood purification treatment for endotoxin-induced acute respiratory distress syndrome
title_sort Continuous blood purification treatment for endotoxin-induced acute respiratory distress syndrome
author Jiang,Y.
author_facet Jiang,Y.
Lin,R.
Xu,Y.
Zhang,S.
Cui,K.
Zhu,M.
Li,A.
Chen,C.
Yang,J.
Yang,W.
author_role author
author2 Lin,R.
Xu,Y.
Zhang,S.
Cui,K.
Zhu,M.
Li,A.
Chen,C.
Yang,J.
Yang,W.
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Jiang,Y.
Lin,R.
Xu,Y.
Zhang,S.
Cui,K.
Zhu,M.
Li,A.
Chen,C.
Yang,J.
Yang,W.
dc.subject.por.fl_str_mv Acute respiratory distress syndrome
Continuous blood purification treatment
Endotoxin
Hemodynamics
topic Acute respiratory distress syndrome
Continuous blood purification treatment
Endotoxin
Hemodynamics
description This study aimed to explore the effects of continuous blood purification (CBP) treatment in pigs affected with acute respiratory distress syndrome (ARDS). A total of 12 healthy male pigs, weighing 12±1.8 kg, were randomly and equally assigned to the control and experimental groups. The ARDS pig model was prepared by intravenous injections of endotoxin (20 µg/kg). The control group was given conventional supportive therapy, while the experimental group was given continuous veno-venous hemofiltration therapy. During the treatment process, the variations in dynamic lung compliance, oxygenation index, hemodynamics, and urine volume per hour at different times (Baseline, 0, 2, 4, and 6 h) were recorded. The levels of tumor necrosis factor (TNF-α), interleukin 6 (IL-6), and IL-10 in serum and bronchoalveolar lavage fluid (BALF) were measured using the enzyme-linked immunosorbent assay. The histomorphological changes of the lung, heart, and kidney were visualized using a light microscope. The nuclear factor κB p65 protein content of the heart, lung, and kidney tissues was also detected using western blot. The experimental group outperformed the control group in both respiratory and hemodynamic events. CBP treatment cleared TNF-α, IL-6, and IL-10 partially from serum and BALF. The pathological examination of the heart, lung, and kidney tissues revealed that the injury was less severe in the experimental group. CBP treatment can improve the organ functions of pigs affected with endotoxin-induced ARDS and protect these organs to some extent.
publishDate 2017
dc.date.none.fl_str_mv 2017-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000200604
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000200604
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1414-431x20165367
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv Brazilian Journal of Medical and Biological Research v.50 n.2 2017
reponame:Brazilian Journal of Medical and Biological Research
instname:Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
instname_str Associação Brasileira de Divulgação Científica (ABDC)
instacron_str ABDC
institution ABDC
reponame_str Brazilian Journal of Medical and Biological Research
collection Brazilian Journal of Medical and Biological Research
repository.name.fl_str_mv Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)
repository.mail.fl_str_mv bjournal@terra.com.br||bjournal@terra.com.br
_version_ 1754302945444233216